Cargando…
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021, we randomly selected 120 seropositive individuals, organi...
Autores principales: | Aguilera, Ximena, Hormazábal, Juan, Vial, Cecilia, Cortes, Lina Jimena, González, Claudia, Rubilar, Paola, Apablaza, Mauricio, Ramírez-Santana, Muriel, Icaza, Gloria, Nuñez-Franz, Loreto, Castillo-Laborde, Carla, Ramírez-Riffo, Carolina, Pérez, Claudia, Quezada-Gate, Rubén, Said, Macarena, Vial, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321248/ https://www.ncbi.nlm.nih.gov/pubmed/35891215 http://dx.doi.org/10.3390/vaccines10071051 |
Ejemplares similares
-
Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
por: Aguilera, Ximena, et al.
Publicado: (2022) -
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
por: Núñez-Franz, Loreto, et al.
Publicado: (2023) -
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
por: Hormazábal, Juan, et al.
Publicado: (2023) -
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile
por: Vial, Pablo, et al.
Publicado: (2022) -
Under five and infant mortality in Chile (1990-2016): Trends,
disparities, and causes of death
por: Aguilera, Ximena, et al.
Publicado: (2020)